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Abstract: Background: Malnutrition-inflammation complex syndrome (MICS) is a common and 
usually concurrent condition occurring in patients undergoing hemodialysis (HD), with a 
pathogenesis linked to biological and in situ environmental traditional risk factors. Periodontitis, 
one of the major types of infection-driven inflammation, often co-occurs in the in the hemodialysis 
population and correlates with markers of malnutrition and inflammation, such as albumin, 
creatinine, and C-reactive protein. Aim: The present study aimed to determine whether the 
periodontal inflammatory status parameters correlate with the albumin, creatinine, and C-reactive 
protein serum concentrations in HD patients, and investigate whether periodontal treatment 
improves these markers of nutritional and systemic inflammation. Materials and Methods: The 
serum creatinine, albumin, and C-reactive Protein (CRP) levels were measured at baseline and after 
non-surgical periodontal treatment, at 3 months and 6 months. Results: At 3 months, a significant 
correlation between plaque index and C-reactive protein (p = 0.012), bleeding on probing and C-
reactive protein (p < 0.0019), and clinical attachment level and C-reactive protein (p = 0.022) was 
found. No significant correlation was found between clinical periodontal parameters and nutrition 
markers at each time. Conclusions: Our results confirmed the association between C-reactive 
protein serum concentration and periodontal inflammatory status, but further research is necessary 
to identify the contributing role of periodontitis on the onset and progression of MICS. 
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1. Introduction 
Inflammation and malnutrition are common in the end stage-renal disease population, affecting 
between 30–60% of dialysis patients. Epidemiological studies have described a substantial association 
between inflammatory state, malnutrition, and atherosclerotic cardiovascular disease, with the co-
occurrence of these conditions linked to poor outcomes [1,2]. The prevalence of chronic inflammatory 
condition in patients undergoing dialysis ranges between 35% and 65%, and increased levels of 
proinflammatory cytokines or acute-phase proteins, especially high-sensitivity C-reactive protein, 
have been observed to be related to adverse prognosis in hemodialysis (HD) patients [3]. The sources 
of inflammation in hemodialysis patients are multifactorial, including patient-related factors such as 
underlying disease, comorbidity, depleted anti-oxidants, infections, obesity, and genetic or 
immunologic factors, or on the other side, HD-related factors, mainly depending on the membrane 
biocompatibility and dialysate quality. Furthermore, the inflammatory state may be due to 
subclinical illnesses. Shifting the balance of good nutritional status versus protein energy 
malnutrition (PEM) state, due to an ecological and nutritional fluxes, may result in malnutrition-
inflammation complex syndrome (MICS) [2,3]. MICS is a common and usually concurrent syndrome 
occurring in patients undergoing HD, with a pathogenesis linked to biological and in situ 
environmental traditional factors [4–6]. MICS is of great concern to clinicians because a high 
prevalence of the HD patients develops this condition. However, the mechanisms underlying the late 
coronary vascular diseases are poorly understood. Periodontitis, one of the major types of infection-
driven inflammation, often co-occurs in the hemodialysis population and correlates with markers of 
malnutrition and inflammation, such as albumin [7], as well as creatinine and C-reactive protein [8–
11]. Periodontal disease is a destructive inflammatory process, caused predominantly by gram-
negative bacteria, involving the supporting structure of teeth [12]. Evidence from studies have 
demonstrated that periodontal disease can induce a systemic inflammatory response and, according 
to data derived from the National Health and Nutrition Examination Survey III NHANES, it is 
associated with increased C-reactive protein level [13,14]. Further, a few studies have suggested a 
potential link between periodontal disease and nutritional markers [15], and also cardiovascular 
disease in patients with end-stage renal disease [3,4]. In this context, recent advances in this field of 
research have hypothesized an intimate link between periodontal inflammation and MICS [2]. 
Several studies have indicated that periodontitis can affect the nutritional and inflammatory status 
in HD patients, suggesting that the condition could be detectable through biochemical analysis of 
serum biomarker levels. However, more investigations are needed to examine the potential 
conditioning role of periodontitis on  the onset or progression of MICS. [8–10]. The present study 
aimed to determine whether the periodontal inflammatory status parameters correlate with the 
albumin, creatinine, and C-reactive protein serum concentrations in HD patients, and investigate 
whether periodontal treatment improves these markers of nutritional and systemic inflammation. 
2. Materials and Methods 
2.1. Patient Population 
This study was conducted in accordance with the Declaration of Helsinki as revised in 2000. 
Written informed study consent was obtained from each subject prior to their inclusion in the study. 
Sixty-six periodontitis patients undergoing hemodialysis, aged 30 to 54 years, were consecutively 
enrolled in the study between November 2017 and January 2018. All subjects met the following 
inclusion criteria: presence of ≥20 teeth and diagnosis of periodontitis according to the criteria of the 
American Academy of Periodontology (2017), receiving hemodialysis for at least one year, ability and 
willingness to give written informed consent for participation in the study, and aged ≥18 years. 
Subjects were excluded if they had severe co-morbidities that would influence periodontal disease 
natural history, cognitive disorders, pregnancy or lactation, or had been taking antibiotics in the 
previous three months. 
2.2. Clinical Examination and Non-Surgical Periodontal Treatment 
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A complete medical history was achieved for each patient, who then underwent a laboratory 
analysis to determine serum concentrations of albumin, creatinine, and C-reactive protein value. 
Serum biomarker measurements were monitored by mean values in each patient at baseline and at 3 
and 6 months follow-up after periodontal treatment [16]. 
Periodontal status was assessed with a manual periodontal probe (UNC-15) by registering the 
following indices at six sites for each tooth (disto-, mid- and mesiobuccal, mesio-, mid-, and 
distolingual): 
• Plaque Index (PI; Löe, 1964) [17]. The tooth surface to be scored was air dried and not 
disclosed. 
• Gingival Index (GI; Löe, 1964 [17]. The gingival index was scored following a 1-mm 
subgingival sweep. 
• Probing Depth (PD), defined as the distance from gingival margin to the bottom of the 
pocket. It was recorded in whole millimeters. 
• Clinical Attachment Level (CAL), defined as the distance from cementoenamel junction 
to the gingival margin. CAL was calculated for six sites per tooth on all teeth present 
in the mouth. 
After baseline, and at 3 months follow-up, each participant received non-surgical periodontal 
treatment (SRP), consisting of mechanical supra- and sub-gingival debridement and root planning 
by quadrant using hand and ultrasonic instruments, as needed, under local anesthesia. Subjects 
received follow-up examinations at 3 and 6 months after completion of therapy. 
3. Statistical Analysis 
Data analysis was performed using SPSSS 20.0 software (IBM Company, New York, NY, USA). 
First, exploratory descriptive analysis was conducted to examine the distribution of periodontal 
disease parameters and serum biomarkers. In evaluating the association between the inflammatory 
periodontal indices and serum concentrations, albumin, creatinine, and CRP were calculated as 
association measurements. The Friedman test was used to detect the differences of medians between 
the variables at three times. A non-parametric approach was preferred because the sample did not 
show evidence of being a population with normal distribution. Probing depth (PD), gingival index, 
plaque index, and clinical attachment level (CAL) were analyzed to identify any correlation with 
albumin, creatinine, and C-reactive protein serum concentrations. 
4. Results 
A total of 66 patients were recruited for the study. Mean time on hemodialysis was 38.5 months. 
The overall mean number of teeth per subject was 21 (SD 3). Table 1 summarizes the mean of clinical 
periodontal parameters and serum biomarkers for baseline and at 3 and 6 months follow-up. As 
showed in Table 2, all periodontal indices improved at 3 and 6 months after non-surgical periodontal 
treatment (p < 0.001); serum albumin decreased at 6 months follow-up (p < 0.001), and serum 
creatinine increased at 6 months follow-up (p = 0.002). Results showed the following correlations: 
• PI at the three time points (chi square = 38.312, p < 0.001): Descriptive statistics 
showed higher average values at T0. Significant differences were present between T0 
and T1 and between T0 and T2; the values between T1 and T2 were closer. 
• GI at the three time points (chi square = 39.569, p < 0.001): Descriptive statistics 
showed higher average values at T0. Significant differences were present between T0 
and T2. 
• Creatinine at the three times points (chi square = 6.063, p = 0.048): The test was 
significant; however, the averages were very similar at the three time points. The 
average at T2 was slightly higher. 
• PD at the three time points (chi square = 20.76, p < 0.001): There was a decrease 
between T0 and T1, while between T1 and T2 the average remained almost constant. 
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• CAL at the three time points (chi square = 13.867, p = 0.001). In this case, there was 
also a decrease between T0 and T1, while between T1 and T2 the average remained 
almost constant. 
Table 1. Descriptive analysis of variables at three time points. 
Indices N Mean 
PI (T0) 
PI (T1) 
PI (T2) 
BoP (T0) 
BoP (T1) 
BoP (T2) 
PD (T0) 
PD (T1) 
PD (T2) 
CAL (T0) 
CAL (T1) 
CAL (T2) 
CREA (T0) 
CREA (T1) 
CREA (T2) 
CRP (T0) 
CRP (T1) 
CRP (T2) 
ALB (T0) 
ALB (T1) 
ALB (T2) 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
66 
42 
15 
12 
37 
14 
11 
2.95 
2.02 
2.09 
3.03 
2.46 
2.38 
1.28 
1.25 
1.32 
0.38 
0.37 
0.57 
3.85 
3.81 
3.62 
Table 2. Friedman’s test for differences of variables at three time points. 
Friedman's Chi-Square Test 
 Chi-Square p-Value gl 
PI 76.62 0.000 2 
BoP 79.138 0.000 2 
PD 41.52 0.000 2 
CAL 27.38 0.000 2 
ALB 132 0.000 2 
CREA 
CRP 
12.125 
0.59 
0.002 
0.744 
2 
2 
As shown in Tables 3, 4, and 5, at 3 months there was significant correlation between plaque 
index and C-reactive protein (p = 0.012), bleeding on probing and C-reactive protein (p < 0.0019), and 
clinical attachment level and C-reactive protein (p = 0.022). There was no significant correlation 
between periodontal indices and albumin and creatinine concentration. At 6 months, a positive 
correlation was found between plaque index and C-reactive protein (p < 0.001), as well as between 
bleeding on probing and C-reactive protein (p < 0.001). Specifically, at T0 there were positive 
correlations between PI and BoP (r = 0.953, p < 0.001), PI and PD (r = 0.644, p < 0.001), PI and CAL (r = 
0.630, p < 0.001), BoP and CAL (r = 0.554, p < 0.001), BoP and PD (r = 0.577, p < 0.001), and between PD 
and CAL (r = 0.957, p < 0.001) (Table 3); at T1 there were positive correlations between PI and BoP (r 
= 0.782, p < 0.001), PI and PD (r = 0.448, p < 0.001), PI and CAL (r = 0.440, p < 0.001), PI and CREA (r = 
0.291, p = 0.018), PI and PCR (r = 0.307, p = 0.012), BoP and PD (r = 0.350, p = 0.004), BoP and CAL (r = 
0.440, p < 0.001), BoP and PCR (r = 0.431, p < 0.001), PD and CAL (r = 0.726, p < 0.001), and PCR and 
CAL (r = 0.283, p = 0.022) (Table 4); at T2 there were positive correlations between PI and BoP (r = 
0.875, p < 0.001), PI and PCR (r = 0.425, p < 0.001), BoP and PCR (r = 0.424, p < 0.001), CREA and PCR 
(r = 0.710, p < 0.001), and between PD and CAL (r = 0.741, p < 0.001). 
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Table 3. Pearson correlation coefficient of variables at T0. 
Pearson Correlation Coefficient 
Timeline PI (T0) BoP (T0) 
ALB 
(T0) 
CREA 
(T0) 
PD 
(T0) 
CAL 
(T0) 
PCR 
(T0) 
PI (T0) 
Pearson 
correlation  
1 0.953** .b 0.185 0.644** 0.630** 0.142 
Sign. (2-sided)  0.000 . 0.137 0.000 0.000 0.255 
N 66 66 66 66 66 66 66 
BoP (T0) 
Pearson 
correlation  
0.953** 1 .b 0.112 0.577** 0.554** 0.191 
Sign. (2-sided) 0.000  . 0.369 0.000 0.000 0.125 
N 66 66 66 66 66 66 66 
ALB 
(T0) 
Pearson 
correlation  
.b .b .b .b .b .b .b 
Sign. (2-sided) . .  . . . . 
N 66 66 66 66 66 66 66 
CREA 
(T0) 
Pearson 
correlation  
0.185 0.112 .b 1 −0.217 −0.188 0.081 
Sign. (2-sided) 0.137 0.369 .  0.081 0.131 0.516 
N 66 66 66 66 66 66 66 
PD (T0) 
Pearson 
correlation  
0.644** 0.577** .b −0.217 1 0.957** 0.073 
Sign. (2-sided) 0.000 0.000 . 0.081  0.000 0.558 
N 66 66 66 66 66 66 66 
CAL 
(T0) 
Pearson 
correlation  
0.630** 0.554** .b −0.188 0.957** 1 0.046 
Sign. (2-sided) 0.000 0.000 . 0.131 0.000  0.712 
N 66 66 66 66 66 66 66 
CRP 
(T0) 
Pearson 
correlation  
0.142 0.191 .b 0.081 0.073 0.046 1 
Sign. (2-sided) 0.255 0.125 . 0.516 0.558 0.712  
N 66 66 66 66 66 66 66 
** The correlation is significant at p < 0.01 (2-sided). b Calculation is impossible to perform because at 
least one of the variables is constant. 
Table 4. Pearson’s correlation coefficient of variables at T1. 
Pearson’s Correlation Coefficient 
 PI (T1)BoP (T1)ALB (T1)CREA (T1) PD (T1)CAL (T1) PCR (T1)
PI (T1) 
Pearson correlation 1 0.782** .b 0.291* 0.448** 0.440** 0.307* 
Sign. (2-sided)  0.000  0.018 0.000 0.000 0.012 
N 66 66 66 66 66 66 66 
BoP (T1) 
Pearson correlation 0.782** 1 .b 0.187 0.350** 0.440** 0.431** 
Sign. (2-sided) 0.000  . 0.133 0.004 0.000 0.000 
N 66 66 66 66 66 66 66 
ALB (T1) 
Pearson correlation .b .b .b .b .b .b .b 
Sign. (2-sided) . . . . . . . 
N 66 66 66 66 66 66 66 
CREA (T1)
Pearson correlation 0.291* 0.187 .b 1 −0.275* −0.304* −0.054 
Sign. (2-sided) 0.018 0.133 . . 0.025 0.013 0.665 
N 66 66 66 66 66 66 66 
PD (T1) 
Pearson correlation 0.448** 0.350** .b −0.275* 1 0.726** 0.155 
Sign. (2-sided) 0.000 0.004 . 0.025 . 0.000 0.215 
N 66 66 66 66 66 66 66 
CAL (T1) Pearson correlation 0.440** 0.440** .b −0.304* 0.726** 1 0.283* 
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Sign. (2-sided) 0.000 0.000  0.013 0.000 . 0.022 
N 66 66 66 66 66 66 66 
CRP (T1) 
Pearson correlation 0.307* 0.431** .b −0.054 0.155 0.283* 1 
Sign. (2-sided) 0.012 0.000 . 0.665 0.215 0.022 . 
N 66 66 66 66 66 66 66 
** The correlation is significant at p < 0.01 (2-sided); * The correlation is significant at p < 0.05 (2-sided). 
b Calculation is impossible to perform because at least one of the variables is constant. 
Table 5. Pearson’s correlation coefficient of variables at T2. 
Pearson Correlation Coefficient 
 PI (T2)BoP (T2)ALB (T2)CREA (T2) PD (T2)CAL (T2) PCR (T2)
PI (T2) 
Pearson correlation 1 0.875** .b 0.251* 0.129 0.326** 0.425** 
Sign. (2-sided) . 0.000 . 0.042 0.304 0.008 0.000 
N 66 66 66 66 66 66 66 
BoP (T2) 
Pearson correlation0.875** 1 .b 0.290* 0.148 0.274* 0.424** 
Sign. (2-sided) 0.000 . . 0.018 0.235 0.026 0.000 
N 66 66 66 66 66 66 66 
ALB (T2) 
Pearson correlation .b .b .b .b .b .b .b 
Sign. (2-sided) . . . . . . . 
N 66 66 66 66 66 66 66 
CREA (T2)
Pearson correlation 0.251* 0.290* .b 1 0.108 0.133 0.710** 
Sign. (2-sided) 0.042 0.018 . . 0.386 0.288 0.000 
N 66 66 66 66 66 66 66 
PD (T2) 
Pearson correlation 0.129 0.148 .b 0.108 1 0.741** 0.259* 
Sign. (2-sided) 0.304 0.235 . 0.386 . 0.000 0.036 
N 66 66 66 66 66 66 66 
CAL (T2) 
Pearson correlation0.326** 0.274* .b 0.133 0.741** 1 0.255* 
Sign. (2-sided) 0.008 0.026 . 0.288 0.000 . 0.039 
N 66 66 66 66 66 66 66 
CRP 
(T2) 
Pearson correlation0.425** 0.424** .b 0.710** 0.259* 0.255* 1 
Sign. (2-sided) 0.000 0.000 . 0.000 0.036 0.039 . 
N 66 66 66 66 66 66 66 
** The correlation is significant at p < 0.01 (2-sided) * The correlation is significant at p < 0.05 (2-sided); 
b Calculation is impossible to perform because at least one of the variables is constant. 
5. Discussion 
In hemodialysis patients, several negative alterations lead to the progression of MICS [13], which 
represents the most common cause of death in this population. The patients undergoing hemodialysis 
are more prone to developing an inflammatory status as well as a state of malnutrition due to 
multiple factors, which range from the bioincompatibility between blood and dialyzer to the presence 
of endotoxins in dialysis fluid and access-related infections [14], and emerging non-traditional risk 
factors [15–19], including exposure to general inflammation [20]. Periodontitis potentially activates 
inflammatory cells and triggers inflammatory signaling pathways, promoting a low-grade systemic 
inflammatory status that could compromise clinical outcomes in patients undergoing hemodialysis 
[21–23]. Elevated circulating levels of acute-phase proteins, including CRP and cytokines such as 
Interleukine-6 IL-6 and Tumor-Necrosis-Factor- α TNF-α [14], have been observed in HD subjects 
[24–26]. Deregulation of this process, leading to uncontrolled chronic inflammation, may induce 
muscle breakdown and hypoalbuminemia [27] and may be implicated in atherogenesis process [28]. 
Increased serum concentrations of pro-inflammatory molecules are known predictors of 
cardiovascular outcomes in the general population as well as in the HD population [29,30]. The 
purpose of the present study was to evaluate the impact of periodontal inflammation on nutritional 
and inflammatory markers in patients undergoing hemodialysis, and to investigate the effect of 
periodontal on the level of these biomarkers. In the evaluation of hemodialysis patients and related 
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periodontal status, biochemical data and clinical parameters were determined at 3 and at 6 month 
follow-up times. Our results provided important information concerning the relationship between 
HD status and periodontal inflammation [31–34]. The limitation of this study is the small size of the 
representative HD population. Despite the reducing indices of periodontal parameters after 
periodontal treatment, we found no statistically significant correlation between periodontal status 
and serum biomarker levels in HD patients, except for CRP. However, the statistical analysis does 
not highlight interindividual differences that emerged in terms of modest improvements in creatinine 
values following non-surgical periodontal treatment [35,36]. These results are in contrast with 
previous studies conducted by Chen et al. [37]. The authors performed a trial that included two-
hundred and fifty-three HD patients, and they aimed to investigate the potential negative impact of 
periodontal infection on hemodialysis status. The researchers found a significant positive correlation 
between biochemical outcomes and periodontal disease parameters [11]. Rodrigues et al. [38], in a 
cross-sectional study, evaluated the association between periodontitis and hematological data, 
including albumin, phosphorus, and other nutritional biomarkers. In this study, a positive 
association of periodontitis with hypoalbuminemia (Odds Ratio (OR) = 9.10, p = 0.006) and a negative 
association with hyperphosphatemia (OR = 0.21, p = 0.010) was observed [39]. The researchers 
hypothesized that periodontal disease could be a key mediating role in the positive association 
between periodontal disease and the onset of inflammatory status in HD patients [40]. However, the 
core mechanisms remain poorly understood. 
6. Conclusions 
Periodontal therapy is not effective in improving albumin and creatinine levels. Despite this 
recognition, the degree to which periodontitis enhances inflammatory and malnutrition status and 
contributes to poor outcomes in hemodialysis patients is still unclear [41–48]. The current research 
was conducted to evaluate the relationship between periodontal inflammation and nutritional and 
inflammation markers in HD patients. The results revealed a positive and significant relationship 
between periodontitis and CRP among the HD population. 
In addition, there was no correlation found between periodontal disease and albumin and 
creatinine serum concentrations. Specifically, the average baseline serum albumin level was lower 
than 4 mg/dL and the average baseline serum creatinine was lower than 1.4 mg/dL, and periodontitis 
was not associated with an albumin and creatinine improvement at 3 and 6 months. To elucidate the 
findings of the present research, it can be said that the absence of a correlation between periodontitis 
and the nutritional markers can potentially be explained as being a result of the brief follow-up. 
Author Contributions: Conceptualization: B.R.; investigation: B.R., E.F., and G.M.N.; resources: F.V., L.C., L.S., 
and E.F.; data curation: B.R. and E.F.; validation: G.M.N., F.C., B.R., S.S., R.G., I.C., and A.G.; writing—original 
draft preparation: B.R., E.F., and G.M.N.; writing—review and editing: B.R., E.F., F.R.G., A.G., I.C., and G.M.N.; 
visualization: L.S. and S.S.; supervision: E.F., G.M.N., and B.R.; project administration: B.R. and G.M.N. 
Funding: This research received no external funding. 
Conflicts of Interest: The authors declare no conflict of interest related to this study. 
References 
1. Yao, Q.; Lindholm, B.; Stenvinkel, P. Inflammation as a cause of malnutrition, atherosclerotic 
cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial. Int. 2004, 8, 118–129. 
2. Joana, R.N.; Lemos, M.G.d.A.; Konrath, A.V.; Cargnin, M.; Manfro, R.C. Flaxseed oil supplementation 
decreases C-reactive protein levels in chronic hemodialysis patients. Nutr. Res. 2012, 32, 921–927, 
doi:10.1016/j.nutres.2012.08.007.  
3. Grubbs, V; Plantinga, L.C.; Crews, D.C.; Bibbins-Domingo, K.; Saran, R; Heung, M; Patel, P.R.; Burrows, 
N.R.; Ernst, K.L.; Powe, N.R.; et al. Vulnerable populations and the association between periodontal and 
chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011, 6, 711–717. 
Antibiotics 2019, 8, 209 8 of 10 
4. Stenvinkel, P.; Heimbürger, O.; Lindholm, B.; Kaysen, G.A.; Bergström, J. Are there two types of 
malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and 
atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant. 2000, 15, 953–960. 
5. Terrier, N.; Senécal, L.; Dupuy, A.; Jaussent, I.; Delcourt, C.; Leray, H.; Rafaelsen, S.; Bosc, J.; Maurice, F.; 
Canaud, B.; Cristol, J. Association between novel indices of malnutrition–inflammation complex syndrome 
and cardiovascular disease in hemodialysis patients. Hemodial. Int. 2005, 9: 159–168. 
6. Kaynar, K.; Songul Tat, T.; Ulusoy, S.; Cansiz, M.; Ozkan, G.; Gul, S.; Bektas, O. Evaluation of nutritional 
parameters of hemodialysis patients. Hippokratia 2012, 16, 236–240. 
7. Anand, N.; Chandrasekaran, S. C.; Alam, M.N. The malnutrition inflammation complex syndrome-the 
micsing factor in the perio-chronic kidney disease interlink. J. Clin. Diagn. Res. 2013, 7, 763–767, 
doi:10.7860/JCDR/2013/5329.2907. 
8. Enia, G.; Sicuso, C.; Alati, G.; Zoccali, C. Subjective Global Assessment of nutrition in dialysis patients. 
Nephrol. Dial. Transplant. 1993, 8, 1094–98. 
9. Suffredini, A.F.; Fantuzzi, G.; Badolato, R.; Oppenheim, J.J.; O’Grady, N.P. New insights into the biology 
of the acute phase response. J. Clin. Immunol. 1999, 19, 203–14. 
10. Qureshi, A.R.; Alvestrand, A.; Divino-Filho, J.C.; Gutierrez, A.; Heimbürger, O.; Lindholm, B.; Bergström 
J. et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. 
J am Soc Nephrol. 2002, 13, S28–S36. 
11. Teeuw, W.J.; Slot, D.E.; Susanto, H.; Gerdes, V.E.; Abbas, F.; D'Aiuto, F.; Kastelein, J.J.; Loos, B.G.; et al. 
Treatment of periodontitis improves the atherosclerotic profile: A systematic review and meta-analysis. J. 
Clin. Periodontol. 2014, 41, 70–79. 
12. Papapanou, PN, Sanz, M, et al. Periodontitis: Consensus report of Workgroup 2 of the 2017 World 
Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J 
Periodontol. 2018; 89(1): S173– S182 
13. Kaysen, G.A.; Chertow, G.M.; Adhikarla, R.; Young, B.; Ronco, C.; Levin, N.W. Inflammation and dietary 
protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney 
Int. 2001, 60, 333–40. 
14. Kalantar-Zadeh, K.; Kopple, J.D.; Block, G.; Humphreys, M.H. A malnutrition-inflammation score is 
correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001, 38, 
1251–63. 
15. Barton, M. Prevention and endothelial therapy of coronary artery disease. Curr. Opin. Pharmacol. 2013, 13, 
226–241. 
16. Strippoli, G.F.; Palmer, S.C.; Ruospo, M.; Natale, P.; Saglimbene, V.; Craig, J.C.; Fabio, P; Massimo P.; 
Michele D.B.; Pauline F.; et al. Oral disease in adults treated with hemodialysis: Prevalence, predictors, and 
association with mortality and adverse cardiovascular events: The rationale and design of the ORAL 
Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, 
cohort study. BMC Nephrol. 2013, 14, 90–90. 
17. Corsalini, M.; Di, V.D.; Carossa, M.; Ripa, M.; Sportelli, P.; Cantatore, F.; De Rinaldis, C.; Di Santantonio, 
G.; Lenoci, G.; Barile, G.; Rapone, B. Comparative clinical study between zirconium-ceramic and metal-
ceramic fixed rehabilitations. Oral Implantol. 2018, 11, 150–160. 
18. Dental Scaling and Root Planing for Periodontal Health: A Review of the Clinical Effectiveness, Cost-effectiveness, 
and Guidelines [Internet]; Canadian Agency for Drugs and Technologies in Health: Ottawa, ON, Canada, 17 
October 2016. 
19. Löe, H. The Gingival Index, the Plaque Index and the Retention Index Systems. J. Periodontol. 1967, 38, 610–
616. 
20. Naghsh, N.; Sabet, N.K.; Vahidi, F.; Mogharehabed, A.; Yaghini, J. Relationship between Periodontal 
Disease and Serum Factors in Patients Undergoing Hemodialysis. Open Dent. J. 2017, 11, 701–709. 
21. Humphrey, L.L.; Fu, R.; Buckley, D.I.; Freeman, M.; Helfand M. Periodontal disease and coronary heart 
disease incidence: A systematic review and meta-analysis. J Gen. Int. Med. 2008, 23, 2079–2086. 
22. Jacobs, L.H.; Van De Kerkhof, J.J.; Mingels, A.M.; Passos, V.L.; Kleijnen, V.W.; Mazairac, A.H.; van der 
Sande, F.M.; Wodzig, W.K.; Konings, C.J.; Leunissen, K.M.; et al. Inflammation, overhydration and cardiac 
biomarkers in haemodialysis patients: A longitudinal study. Nephrol. Dial. Transpl. 2010, 25, 243–248. 
Antibiotics 2019, 8, 209 9 of 10 
23. Kalantar-Zadeh, K.; Regidor, D.L.; Kovesdy, C.P.; Van Wyck, D.; Bunnapradist, S.; Horwich, T.B.; Fonarow 
G.C. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term 
hemodialysis. Circulation. 2009, 119, 671–679. 
24. Kaynar, K.; Songul Tat, T.; Ulusoy, S.; Cansiz, M.; Ozkan, G.; Gul, S.; Bektas, O. Evaluation of nutritional 
parameters of hemodialysis patients. Hippokratia 2012, 16, 236–240. 
25. Dekker, M.J.E. Marcelli, D.; Canaud, B.J.; Carioni, P.; Wang, Y.; Grassmann, A.; Konings, C.J.; Kotanko P.; 
Leunissen, K.M.; Levin, N.W.; et al. Impact of fluid status and inflammation and their interaction on 
survival: A study in an international hemodialysis patient cohort. Kidney International, 2017, 91, 1214–1223. 
26. Sproston, NR; Ashworth, J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. 
Immunol. 2018, 9, 754. 
27. Di Comite, M.; Crincoli, V.; Fatone, L.; Ballini, A.; Mori, G.; Rapone, B.; Boccaccio, A.; Pappalettere, C.; 
Grassi, F.R.; Favia, A. Quantitative analysis of defects at the dentin-post space in endodontically treated 
teeth. Materials 2015, 8, 3268–3283. doi: 10.3390/ma8063268. 
28. Grassi, F.R.; Rapone, B.; Scarano Catanzaro, F.; Corsalini, M.; Kalemaj, Z. Effectiveness of computer-
assisted anesthetic delivery system (STA™) in dental implant surgery: A prospective study. Oral Implantol. 
2017, 10, 381–389. doi: 10.11138/orl/2017.10.4.381. 
29. Kalemaj, Z.; Scarano, A.; Valbonetti, L.; Rapone, B.; Grassi, F.R. Bone response to four dental implants with 
different surface topography: A histologic and histometric study in minipigs. Int. J. Periodontics Restor. Dent. 
2016, 36, 745–754. doi: 10.11607/prd.2719. 
30. Rahmati, M.A.; Craig, R.G.; Homel, P.; Kaysen, G.A.; Levin, N.W. Serum markers of periodontal disease 
status and inflammation in hemodialysis patients. Am. J. Kidney Dis. 2002, 40, 983–989. 
31. Di Venere, D.; Pettini, F.; Nardi, G.M.; Laforgia, A.; Stefanachi, G.; Notaro, V.; Rapone, B.; Grassi, F.R.; 
Corsalini, M. Correlation between parodontal indexes and orthodontic retainers: Prospective study in a 
group of 16 patients. Oral Implantol. 2017, 10, 78–86. doi:10.11138/orl/2017.10.1.078. 
32. Palmer, S.C.; Ruospo, M.; Wong, G.; Craig, J.C.; Petruzzi, M.; De Benedittis, M.; Ford, P.; Johnson, D.W.; 
Tonelli, M.; Natale P.; et al. Dental health and mortality in people with end-stage kidney disease treated 
with hemodialysis: A multinational cohort study. Am. J. Kidney Dis. 2015, 66, 666–676. 
33. Kim, G.H.; Choi, B.S.; Cha, D.R.; Chee, D.H.; Hwang, E.; Kim, H.W.; Chang, J.H.; Kim, J.K.; Noh, J.W.; Joo 
K.W.; et al. Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A 
multicentre study in Korea. Kidney Res. Clin. Pract. 2014, 33, 52–57. 
34. Rapone, B.; Nardi, G.M.; Di Venere, D.; Pettini, F.; Grassi, F.R.; Corsalini, M. Oral hygiene in patients with 
oral cancer undergoing chemotherapy and/or radiotherapy after prosthesis rehabilitation: Protocol 
proposal. Oral Implantol. 2016, 9 (Suppl. 1), 90–97. 
35. Corsalini, M.; Di Venere, D.; Rapone, B.; Stefanachi, G.; Laforgia, A.; Pettini, F. Evidence of signs and 
symptoms of Craniomandibular Disorders in Fibromyalgia patients. Open Dent. J. 2017, 11, 91–98. 
doi:10.2174/1874210601711010091. 
36. Di Venere, D.; Nardi, G.M.; Lacarbonara, V.; Laforgia, A.; Stefanachi, G.; Corsalini, M.; Grassi, F.R.; Rapone, 
B.; Pettini, F. Early mandibular canine-lateral incisor transposition: Case Report. Oral Implantol. 2017, 10, 
181–189. doi:10.11138/orl/2017.10.2.181. 
37. Di Venere, D.; Corsalini, M.; Nardi, G.M.; Laforgia, A.; Grassi, F.R.; Rapone, B.; Pettini, F. Obstructive site 
localization in patients with Obstructive Sleep Apnea Syndrome: A comparison between otolaryngologic 
data and cephalometric values. Oral Implantol. 2017 , 10, 295–310. doi:10.11138/orl/2017.10.3.295. 
38. Rapone, B.; Ferrara, E.; Santacroce, L.; Cesarano, F.; Arazzi, M.; Di Liberato, L.; Scacco, S.; Grassi, R.; Grassi, 
F.R.; Gnoni, A.; et al. Periodontal Microbiological Status Influences the Occurrence of Cyclosporine-A and 
Tacrolimus- Induced Gingival Overgrowth. Antibiotics 2019, 8, 124. doi:10.3390/antibiotics8030124. 
39. Chen, L.P.; Chiang, C.K.; Chan, C.P.; Hung, K.Y.; Huang, C.S. Does Periodontitis Reflect Inflammation and 
Malnutrition Status in Hemodialysis Patients? Am. J. Kidney Dis. 2006, 47, 815–822. 
40. Rodrigues, VP; Libério, S.A.; Lopes, F.F.; Thomaz, E.B.F.A.; Guerra, R.N.M.; Gomes-Filho, I.S.; Pereira, 
A.L.A. Periodontal status and serum biomarkers levels in haemodialysis patients. J. Clin. Periodontol. 2014, 
41, 862–868. doi: 10.1111/jcpe.12283. 
41. Notaro, V.; Rapone, B.; Cagnetta, G.; Sportelli, P.; Nardi, G.M.; Corsalini, M.s Resonance frequency 
evaluation on immediate loading implants with angled abutments: Case series. Ann. di Stomatol. 2018, 9, 
91–96. doi: 10.11138/ads/2018.9.2.091. 
Antibiotics 2019, 8, 209 10 of 10 
42. Nardi, G.M.; Sabatini, S.; Guerra F.; Marco, T.; Livia, O. Tailored brushing method (TBM): An innovative 
simple protocol to improve the oral care. J. Biomed. 2016, 1, 26–31. 
43. Nardi, G.M.; Grassi, R.; Grassi, F.R.; Aragona, S.E.; Rapone, B.; Della Vella, F.; Sabatini, S. Use of 
photobiomodulation induced by polarized polychromatic non-coherent light in the management of adult 
chronic periodontitis. J. Biol. Regul. Homeost Agents 2019, 33, 293–297 
44. Corsalini, M.; Di Venere, D.; Sportelli, P.; Magazzino, D.; Ripa, M.; Cantatore, F.; Cagnetta, C.; De Rinaldis, 
C.; Montemurro, N.; De Giacomo, A.; et al. Evaluation of prosthetic quality and masticatory efficiency in 
patients with total removable prosthesis: Study of 12 cases. Oral Implantol. 2018, 11, 230–240. 
45. Grassi, F.R.; Grassi, R.; Rapone, B.; Gianfranco, A.; Balena, A.; Kalemaj, Z. Dimensional changes of buccal 
bone plate in immediate implants inserted through open flap, open flap and bone grafting, and flapless 
technique. A CBCT randomized controlled clinical trial. Clin. Oral Implant. Res. 2019, doi:10.1111/clr.13528. 
46. Quaglia, E.; Moscufo, L.; Corsalini, M.; Coscia, D.; Sportelli, P.; Cantatore, F.; De Rinaldis, C.; Rapone, B.; 
Carossa, M.; Carossa, S. Polyamide vs silk sutures in the healing of postextraction sockets: A split mouth 
study. Oral Implantol. 2018, 11, 115–120. doi:10.11138/orl/2018.11.2.115. 
47. Corsalini, M.; Rapone, B.; Di Venere, D.; Petruzzi, M. Removable prosthetic treatment in oral pemphigus 
vulgaris: Report of three cases. J. Int. Soc. Prev. Communit. Dent. 2019, 9, 423–426. 
48. Tonbul, H.Z.; Demir, M.; Altintepe, L.; Güney, I.; Yeter, E.; Türk, S.; Yeksan, M.; Yildiz, A. Malnutrition-
inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis 
patients. Ren. Fail. 2006, 28, 287–294. 
 
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an 
open access article distributed under the terms and conditions of the Creative 
Commons Attribution (CC BY) license 
(http://creativecommons.org/licenses/by/4.0/). 
 
 
